Evidence map›Paper›PMID 39009685›Full record

ArticleScientific reports2024

Genomic surveillance of malaria parasites in an indigenous community in the Peruvian Amazon.

Luis Cabrera-Sosa, Oscar Nolasco, Johanna H Kattenberg, Carlos Fernandez-Miñope, Hugo O Valdivia, Keare Barazorda, Silvia Arévalo de Los Rios, Hugo Rodriguez-Ferrucci, Joseph M Vinetz, Anna Rosanas-Urgell and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Malaria control and the unexpected spread of diagnostic-resistantbioRxiv : the preprint server for biology · 2026
    Article
  6. Next-generation molecular tools in veterinary parasitology: advances, challenges, and perspectives in the diagnosis of emerging parasites.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2026
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Luis Cabrera-SosaLaboratorio de Malaria: Parásitos y Vectores, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Peru. luis.cabrera@upch.pe.
Oscar NolascoLaboratorio de Malaria: Parásitos y Vectores, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Peru.
Johanna H KattenbergDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Carlos Fernandez-MiñopeInstituto de Medicina Tropical "Alexander Von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Hugo O ValdiviaDepartment of Parasitology, U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), Lima, Peru.
Keare BarazordaDepartment of Parasitology, U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), Lima, Peru.
Silvia Arévalo de Los RiosLaboratorio de Salud Pública de Loreto, Gerencia Regional de Salud de Loreto, Iquitos, Loreto, Peru.
Hugo Rodriguez-FerrucciFacultad de Medicina Humana, Universidad Nacional de la Amazonía Peruana, Iquitos, Loreto, Peru.
Joseph M VinetzInstituto de Medicina Tropical "Alexander Von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru.
Anna Rosanas-UrgellDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Jean-Pierre Van GeertruydenMalaria Research Group (MaRch), Global Health Institute (GHI), Family Medicine and Population Health Department (FAMPOP), Faculty of Medicine, University of Antwerp, Antwerp, Belgium.
Dionicia GamboaLaboratorio de Malaria: Parásitos y Vectores, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Peru.
Christopher Delgado-RattoInstituto de Medicina Tropical "Alexander Von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru. chris.delgadoratto@uantwerpen.be.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Sugar-feeding behavior of the malaria vector Nyssorhynchus darlingi and development of effective attractive toxic sugar baits (ATSB) to increase intervention success in PeruU19AI089681 · NIAID · YALE UNIVERSITY · PI GAZZINELLI, RICARDO TOSTES · 2010 to 2023
$20.1M
Armed Forces Health Surveillance Division (AFHSD-GEIS) P0134_23_N6Belgium Development Cooperation (DGD) FA4 Peru (2017 - 2021)Belgium Development Cooperation (DGD) FA5 Peru (2022 - 2026)Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica 165-2020-FONDECYTFonds Wetenschappelijk Onderzoek G.0A42.22NNCATS NIH HHS UL1 TR001863NIAID NIH HHS U19 AI089681NIH HHS 5U19AI089681-15VLIR-UOS, Belgium PE2018TEA470A102
6 · The paper itself

Abstract

Hard-to-reach communities represent Peru's main challenge for malaria elimination, but information about transmission in these areas is scarce. Here, we assessed Plasmodium vivax (Pv) and P. falciparum (Pf) transmission dynamics, resistance markers, and Pf hrp2/3 deletions in Nueva Jerusalén (NJ), a remote, indigenous community in the Peruvian Amazon with high population mobility. We collected samples from November 2019 to May 2020 by active (ACD) and passive case detection (PCD) in NJ. Parasites were identified with microscopy and PCR. Then, we analyzed a representative set of positive-PCR samples (Pv = 68, Pf = 58) using highly-multiplexed deep sequencing assays (AmpliSeq) and compared NJ parasites with ones from other remote Peruvian areas using population genetics indexes. The ACD intervention did not reduce malaria cases in the short term, and persistent malaria transmission was observed (at least one Pv infection was detected in 96% of the study days). In Nueva Jerusalen, the Pv population had modest genetic diversity (He = 0.27). Pf population had lower diversity (He = 0.08) and presented temporal clustering, one of these clusters linked to an outbreak in February 2020. Moreover, Pv and Pf parasites from NJ exhibited variable levels of differentiation (Pv Fst = 0.07-0.52 and Pf Fst = 0.11-0.58) with parasites from other remote areas. No artemisin resistance mutations but chloroquine (57%) and sulfadoxine-pyrimethamine (35-67%) were detected in NJ's Pf parasites. Moreover, pfhrp2/3 gene deletions were common (32-50% of parasites with one or both genes deleted). The persistent Pv transmission and the detection of a Pf outbreak with parasites genetically distinct from the local ones highlight the need for tailored interventions focusing on mobility patterns and imported infections in remote areas to eliminate malaria in the Peruvian Amazon.

Indexed as

Malaria, FalciparumMalaria, VivaxPlasmodium falciparumPlasmodium vivaxProtozoan ProteinsAdolescentAdultAntigens, ProtozoanAntimalarialsChildChild, PreschoolDrug ResistanceFemaleGenetic VariationGenomicsHumansAntigens, ProtozoanAntimalarialsProtozoan ProteinsDrug resistanceGenetic diversityHRP2Malaria eliminationMalaria persistencePopulation genetics

Identifiers

PMID39009685
PMCPMC11250820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.